New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery system to be used in adult cholecystectomies.

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...

NeuroPace has reported the initial primary endpoint one-year outcomes from the NAUTILUS trial of the RNS System.

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

SAGA Diagnostics has commercially launched the multi-cancer molecular residual disease (MRD) platform, Pathlight, in the US.